SECURITY AGREEMENTSecurity Agreement • May 4th, 2011 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SECURITY AGREEMENT, dated as of April 28, 2011, made by Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Grantor”), in favor of NexBank SSB, a Texas-chartered savings bank (“NexBank”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”) acting pursuant to this Agreement for the benefit of the Secured Parties (as defined in the Credit Agreement referred to below).
SENIOR SECURED SUPER PRIORITY DEBTOR-IN-POSSESSION CREDIT AGREEMENT by and among MOLECULAR INSIGHT PHARMACEUTICALS, INC. as Debtor and Debtor-in- Possession, The Lenders from Time to Time Party Hereto, and NEXBANK, SSB, as Administrative Agent and...Credit Agreement • May 4th, 2011 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS CREDIT AGREEMENT, dated as of April 28, 2011, is among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation as a debtor and debtor-in-possession under Chapter 11 of the Bankruptcy Code (the “Borrower”), the lenders from time to time party hereto (each a “Lender” and, collectively, the “Lenders”) and NexBank, SSB, a Texas-chartered savings bank (“NexBank”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”) and NexBank, as collateral agent for the Secured Parties (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”, and together with the Administrative Agent, collectively, the “Agents” and each an “Agent”).
